Abstract Number: 479 • 2019 ACR/ARP Annual Meeting
Impact of Achieving Early-sustained Remission on Preventing Long-term Functional Loss in Patients with Early Rheumatoid Arthritis
Background/Purpose: Preventing functional loss is crucial to early RA (ERA) patients in order to maintain usual activities of daily living. However, whether achieving early and…Abstract Number: 480 • 2019 ACR/ARP Annual Meeting
Not Achieving Clinical Remission Predicts a Poor Health-Related Quality of Life in Rheumatoid Arthritis Patients: Results of a Latin American Real World Database
Background/Purpose: Uncontrolled Rheumatoid Arthritis (RA) leads to disability, damage, and poor health-related quality of life (HRQoL). Current treatment recommendations emphasize the importance of achieving remission…Abstract Number: 481 • 2019 ACR/ARP Annual Meeting
Production of IL17A in Synovial Tissue Correlates with MRI RAMRIS Scores in ACPA Positive Early Rheumatoid Arthritis
Background/Purpose: We previously studied evolution of MRI RAMRIS scores in a group of 28 early rheumatoid (RA) patients treated with first-line infliximab (IFX) versus placebo.…Abstract Number: 482 • 2019 ACR/ARP Annual Meeting
Antibody Repertoire Sequencing, Antigen Array Analysis, and Cytokine Profiling of Blood from Individuals at High-risk for RA Reveals Candidate Immunoglobulin V Genes, ACPA, and Cytokines That May Promote the Transition to Arthritis
Background/Purpose: The “Targeting Immune Responses for Prevention of RA” (TIP-RA) collaboration studies individuals at high risk for developing rheumatoid arthritis (RA) because of serum anti-citrullinated…Abstract Number: 483 • 2019 ACR/ARP Annual Meeting
Can a Single Question on Functional Impairments Facilitate the Diagnosis of Early Inflammatory Arthritis? A Cross-Sectional Derivation and Validation Study in Two Early Arthritis Recognition Clinics
Background/Purpose: Early treatment initiation in RA is associated with improved outcomes but requires early identification of synovitis. Joint swelling in early inflammatory arthritis (IA) may…Abstract Number: 484 • 2019 ACR/ARP Annual Meeting
Effectiveness of Platelet-derived Microparticles for the Diagnosis and Clinical Evaluation of Rheumatoid Arthritis
Background/Purpose: Platelet-derived microparticles (PDMP) are membrane vesicles released from activated platelets and contain various inflammatory or angiogenetic factors; therefore, PDMP may be a new biomarker…Abstract Number: 485 • 2019 ACR/ARP Annual Meeting
Comparison of Clinical Features, Synovial Histology and Immunohistochemistry in Seropositive Arthralgia, Rheumatoid Arthritis, and Osteoarthritis
Background/Purpose: Seropositive arthralgia is defined as joint pain in patients positive for rheumatoid factor (RF) or anti-citrullinated protein antibodies (ACPA). It is a precursor to…Abstract Number: 486 • 2019 ACR/ARP Annual Meeting
Evolution of Seropositive Arthralgia over Time: Predictors of Evolution to Rheumatoid Arthritis
Background/Purpose: Seropositive arthralgia is defined as joint pain in patients positive for rheumatoid factor (RF) or anti-citrullinated protein antibodies (ACPA). In some individuals it is…Abstract Number: 487 • 2019 ACR/ARP Annual Meeting
Third Generation Anti-cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Second Generation Anti-cyclic Citrullinated Peptide Positive Subjects at Risk of Rheumatoid Arthritis
Background/Purpose: ACPA positive individuals with musculoskeletal symptoms are at increased risk of developing RA. In such individuals, ACPA are conventionally identified on the basis of…Abstract Number: 488 • 2019 ACR/ARP Annual Meeting
Citrullinated Antigens with Multiple Citruline Similar Motif Could Be Used for RA Diagnosis
Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic joint inflammation that ultimately leads to joint destruction. Diagnosis of RA is important…Abstract Number: 489 • 2019 ACR/ARP Annual Meeting
S100A11 (calgizzarin) Is Released During Neutrophil Extracellular Traps (NETs) Formation in Rheumatoid Arthritis (RA)
Background/Purpose: S100A11 protein, a member of S100 family, has been associated with several autoimmune inflammatory conditions such as rheumatoid arthritis (RA). Moreover, its pro-inflammatory effect…Abstract Number: 490 • 2019 ACR/ARP Annual Meeting
Validation of Risk Scores for Predicting Progression in Individuals “At Risk of Rheumatoid Arthritis”
Background/Purpose: Risk scores for progression have been described in 2015 in a cohort of 100 anti-cyclic citrullinated peptide (anti-CCP) positive individuals at risk of developing…Abstract Number: 491 • 2019 ACR/ARP Annual Meeting
Diagnostic Performance of Anti-cyclic Citrullinated Peptide (CCP) 2 and CCP3.1 Assays in Early Rheumatoid Arthritis
Background/Purpose: Anti-cyclic citrullinated peptide (CCP) antibodies are the most specific markers for rheumatoid arthritis (RA). Different generations of assays (CCP1-CCP3) have been developed which show…Abstract Number: 492 • 2019 ACR/ARP Annual Meeting
‘It Felt Like I Was Walking on Rocks” Patients Share First Symptoms of RA
Background/Purpose: Background: Although early diagnosis and treatment are pivotal for successful outcomes in rheumatoid arthritis (RA), a gap remains in our understanding of its earliest…Abstract Number: 493 • 2019 ACR/ARP Annual Meeting
Diversity Analysis of Intestinal Flora in Patients with Rheumatoid Arthritis
Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammation of the synovial joints. The gut microbe with RA has been reported recently,…
ACR Meeting Abstracts